Table 4.

Comparison of immune function between the two groups before and after treatment (x̅±s, %)

Group	Number of cases	CD3+		t	P	CD4+		t	P
		Before treatment	After treatment			Before treatment	After treatment
Observation group	56	47.35±9.42	58.25±12.54	5.201	0.000	40.15±5.46	49.17±6.23	8.148	0.000
Control group	56	47.03±9.55	52.61±10.23	2.984	0.004	40.38±5.57	45.21±5.89	4.459	0.000
t		0.179	2.608			0.221	3.457
P		0.859	0.010			0.826	0.001
Group	Number of cases	CD8+		t	P	CD4+/CD8+		t	P
		Before treatment	After treatment			Before treatment	After treatment
Observation group	56	28.03±5.16	20.14±5.25	8.021	0.000	1.43±0.28	1.95±0.37	8.386	0.000
Control group	56	28.17±5.38	25.01±5.47	3.082	0.003	1.40±0.25	1.71±0.32	5.713	0.000
t		0.141	4.807			0.598	3.671
P		0.889	0.000			0.551	0.000